chr2-27079075-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_007046.4(EMILIN1):​c.10C>G​(p.Arg4Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000554 in 1,444,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R4H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

EMILIN1
NM_007046.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.86

Publications

0 publications found
Variant links:
Genes affected
EMILIN1 (HGNC:19880): (elastin microfibril interfacer 1) This gene encodes an extracellular matrix glycoprotein that is characterized by an N-terminal microfibril interface domain, a coiled-coiled alpha-helical domain, a collagenous domain and a C-terminal globular C1q domain. The encoded protein associates with elastic fibers at the interface between elastin and microfibrils and may play a role in the development of elastic tissues including large blood vessels, dermis, heart and lung. [provided by RefSeq, Sep 2009]
EMILIN1 Gene-Disease associations (from GenCC):
  • neuronopathy, distal hereditary motor, autosomal dominant 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.029959232).
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EMILIN1NM_007046.4 linkc.10C>G p.Arg4Gly missense_variant Exon 1 of 8 ENST00000380320.9 NP_008977.1 Q9Y6C2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EMILIN1ENST00000380320.9 linkc.10C>G p.Arg4Gly missense_variant Exon 1 of 8 1 NM_007046.4 ENSP00000369677.4 Q9Y6C2-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000454
AC:
1
AN:
220166
AF XY:
0.00000815
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000103
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000554
AC:
8
AN:
1444010
Hom.:
0
Cov.:
31
AF XY:
0.00000696
AC XY:
5
AN XY:
718666
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31634
American (AMR)
AF:
0.00
AC:
0
AN:
43030
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25478
East Asian (EAS)
AF:
0.0000269
AC:
1
AN:
37214
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85556
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51204
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5626
European-Non Finnish (NFE)
AF:
0.00000543
AC:
6
AN:
1104770
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jul 14, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.10C>G (p.R4G) alteration is located in exon 1 (coding exon 1) of the EMILIN1 gene. This alteration results from a C to G substitution at nucleotide position 10, causing the arginine (R) at amino acid position 4 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
1.2
DANN
Benign
0.77
DEOGEN2
Benign
0.052
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.060
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.030
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
-1.9
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.037
Sift
Benign
0.78
T
Sift4G
Uncertain
0.045
D
Polyphen
0.0
B
Vest4
0.041
MutPred
0.31
Gain of catalytic residue at R4 (P = 0.0427);
MVP
0.41
MPC
0.24
ClinPred
0.070
T
GERP RS
-2.6
PromoterAI
0.098
Neutral
Varity_R
0.081
gMVP
0.39
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757030616; hg19: chr2-27301943; API